Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. [electronic resource]
Producer: 20161104Description: 203-16 p. digitalISSN:- 1463-1326
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- blood
- Dipeptidyl-Peptidase IV Inhibitors -- pharmacology
- Glucagon-Like Peptide-1 Receptor -- therapeutic use
- Humans
- Hypoglycemic Agents -- pharmacology
- Incretins -- pharmacology
- Insulin -- metabolism
- Insulin Secretion
- Insulin-Secreting Cells -- metabolism
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.